Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Geroscience|February 25, 2021
IL-6 can singlehandedly drive many features of frailty in miceMladen Jergović, Heather L Thompson, Christine M Bradshaw, et al.Neurology|July 7, 2021
Recommendations for Measurement of Attention Outcomes in Preschoolers With NeurofibromatosisBonita P Klein-Tasman, Kristin Lee, Heather L Thompson, et al.Aging Cell|November 16, 2018
Lymph nodes as barriers to T-cell rejuvenation in aging mice and nonhuman primatesHeather L Thompson, Megan J Smithey, Jennifer L Uhrlaub, et al.Neurology|August 17, 2016
Patient-reported outcomes of pain and physical functioning in neurofibromatosis clinical trialsPamela L Wolters, Staci Martin, Vanessa L Merker, et al.Clinical Trials (London, England)|December 23, 2023
Recommendations for assessing appearance concerns related to plexiform and cutaneous neurofibromas in neurofibromatosis 1 clinical trialsVanessa L Merker, Heather L Thompson, Pamela L Wolters, et al.Neurology|August 17, 2016
Neurocognitive outcomes in neurofibromatosis clinical trials: Recommendations for the domain of attentionKarin S Walsh, Jennifer Janusz, Pamela L Wolters, et al.Neurology|July 7, 2021
Current Recommendations for Patient-Reported Outcome Measures Assessing Domains of Quality of Life in Neurofibromatosis Clinical TrialsPamela L Wolters, Ana-Maria Vranceanu, Heather L Thompson, et al.Neurology|July 7, 2021
Recommendations for Social Skills End Points for Clinical Trials in Neurofibromatosis Type 1Jennifer A Janusz, Bonita P Klein-Tasman, Jonathan M Payne, et al.Pageof 3